FGFR Alterations and FGFR mRNA Expression as Prognostic Indicators in Metastatic Urothelial Cancer Treated With Checkpoint Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy
Urology 2021 Jun 18;[EPub Ahead of Print], K Tully, H Jütte, RM Wirtz, J Jarczyk, A Santiago-Walker, F Zengerling, J Breyer, D Sikic, MC Kriegmair, J von Hardenberg, B Wullich, H Taubert, V Weyerer, R Stoehr, C Bolenz, M Burger, S Porubsky, A Hartmann, F Roghmann, P Erben, M EcksteinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.